Joseph H Capper bought $1.3M of Mimedx (MDXG)

Executed May 2 2025, disclosed May 5 2025, 3 days later.

Value, as filed

$1.3M

200,000 sh × $6.34

Executed

May 2 2025

the trade date, as filed

Disclosed

May 5 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+2.5%

+0.9% from execution

Over the 21 trading sessions from the disclosed entry session (May 5 2025), the stock returned +2.5% (delay-adjusted); from the execution session (May 2 2025), +0.9%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

JC Joseph H Capper Chief Executive Officer profile →

Joseph H Capper (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in MDXG. Across 1 priced purchase filing, the average 21-session return was +0.9% from execution and +2.5% from disclosure (delay-adjusted; derived). The largest single filing was $1.3M of MDXG (200,000 sh × $6.34, as filed), executed May 2 2025.

The name

MDXG MDXG MDXG · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→